• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

直接多巴胺受体激动剂与左旋多巴联合给药并不干扰大鼠纹状体内外源性左旋多巴的利用。

Combined administration of direct dopamine receptor agonists and L-dopa does not interfere with utilization of exogenous L-dopa in rat corpus striatum.

作者信息

Globus M, Melamed E

出版信息

Prog Neuropsychopharmacol Biol Psychiatry. 1983;7(2-3):211-5. doi: 10.1016/0278-5846(83)90109-4.

DOI:10.1016/0278-5846(83)90109-4
PMID:6310691
Abstract

The effect of combined administration of L-dopa with apomorphine or with bromocriptine on rat striatal concentrations of dopamine (DA), dihydroxyphenylacetic (DOPAC) and dopa was investigated. Injections of apomorphine or bromocriptine alone decreased striatal DOPAC levels indicating suppression of DA turnover in nigrostriatal terminals. The dopa-induced elevations in striatal concentrations of DA, DOPAC and dopa were similar among animals injected with L-dopa alone or in combination with apomorphine or bromocriptine. These findings suggest that although direct DA receptor agonists decrease striatal DA turnover, they do not interfere with utilization of exogenous L-dopa in striatum.

摘要

研究了左旋多巴与阿扑吗啡或溴隐亭联合给药对大鼠纹状体中多巴胺(DA)、二羟基苯乙酸(DOPAC)和多巴浓度的影响。单独注射阿扑吗啡或溴隐亭可降低纹状体DOPAC水平,表明黑质纹状体终末的DA周转受到抑制。在单独注射左旋多巴或与阿扑吗啡或溴隐亭联合注射的动物中,多巴引起的纹状体DA、DOPAC和多巴浓度升高相似。这些发现表明,尽管直接DA受体激动剂可降低纹状体DA周转,但它们并不干扰纹状体中外源性左旋多巴的利用。

相似文献

1
Combined administration of direct dopamine receptor agonists and L-dopa does not interfere with utilization of exogenous L-dopa in rat corpus striatum.直接多巴胺受体激动剂与左旋多巴联合给药并不干扰大鼠纹状体内外源性左旋多巴的利用。
Prog Neuropsychopharmacol Biol Psychiatry. 1983;7(2-3):211-5. doi: 10.1016/0278-5846(83)90109-4.
2
Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease.多巴胺受体:左旋多巴和溴隐亭长期治疗对帕金森病动物模型的影响
Clin Neuropharmacol. 1984;7(3):247-57.
3
The effect of chronic bromocriptine and L-dopa on spiperone binding and apomorphine-induced stereotypy.慢性溴隐亭和左旋多巴对司哌隆结合及阿扑吗啡诱导的刻板行为的影响。
Psychopharmacology (Berl). 1982;78(1):81-4. doi: 10.1007/BF00470594.
4
Does treatment with dopamine agonists affect utilization of exogenous levodopa in the parkinsonian striatum?
J Neural Transm Suppl. 1995;45:57-60.
5
Behavioural and biochemical alterations in the function of dopamine receptors following repeated administration of L-DOPA to rats.对大鼠反复给予左旋多巴后多巴胺受体功能的行为学和生物化学改变。
Neuropharmacology. 1984 May;23(5):545-53. doi: 10.1016/0028-3908(84)90028-5.
6
Suppression of MPTP-induced dopaminergic neurotoxicity in mice by nomifensine and L-DOPA.诺米芬辛和左旋多巴对小鼠MPTP诱导的多巴胺能神经毒性的抑制作用。
Brain Res. 1985 Sep 9;342(2):401-4. doi: 10.1016/0006-8993(85)91146-1.
7
Coadministration of β-asarone and levodopa increases dopamine in rat brain by accelerating transformation of levodopa: a different mechanism from Madopar.β-细辛醚与左旋多巴联合给药通过加速左旋多巴的转化增加大鼠脑内多巴胺:一种不同于美多芭的作用机制。
Clin Exp Pharmacol Physiol. 2014 Sep;41(9):685-90. doi: 10.1111/1440-1681.12270.
8
Dopamine release in rat striatum after administration of L-dope as studied with in vivo electrochemistry.用体内电化学方法研究L-多巴给药后大鼠纹状体中的多巴胺释放。
Brain Res. 1981 Nov 30;225(2):333-46. doi: 10.1016/0006-8993(81)90840-4.
9
Behavioral and biochemical evidence for a different effect of repeated administration of L-dopa and bromocriptine on denervated versus non-denervated striatal dopamine receptors.左旋多巴和溴隐亭重复给药对去神经支配与未去神经支配的纹状体多巴胺受体产生不同影响的行为学和生物化学证据。
Neuropharmacology. 1987 Nov;26(11):1601-6. doi: 10.1016/0028-3908(87)90008-6.
10
Alteration of striatal dopaminergic functions implicated in methamphetamine-induced reverse tolerance in rats.纹状体多巴胺能功能的改变与大鼠甲基苯丙胺诱导的反向耐受有关。
Eur J Pharmacol. 1986 Apr 16;123(2):287-94. doi: 10.1016/0014-2999(86)90670-9.